AM
Therapeutic Areas
Recordati Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cushing's Disease Portfolio | Cushing's Disease | Commercial |
| Acromegaly Treatments | Acromegaly | Commercial |
| Porphyria Therapies | Porphyria | Commercial |
| Neuroblastoma Treatment | High-risk Neuroblastoma | Commercial |
| Cardiovascular Portfolio | Heart Conditions | Commercial |
| Urology Products | Prostate Cancer/Conditions | Commercial |
Leadership Team at Recordati
RK
Robert Koremans
Chief Executive Officer
MM
Mike McClellan
Chief Financial Officer
SP
Scott Pescatore
Executive VP Rare Diseases Business Unit
MZ
Milan Zdravkovic
Executive VP Research & Development and Chief Medical Officer
BB
Bibianne Bon
Group Chief Legal Officer
AA
Alessandra Abate
Group Chief People and Culture Officer
GF
Gabriele Finzi
Executive VP Corporate Development, Licensing & Innovation
AG
Alessandro Gilio
Executive VP Group Industrial Operations
SP
Stefania Pesce
ESG Manager
LC
Laura Conti
Group Communications Director